329 related articles for article (PubMed ID: 37332750)
21. Fibrinolytic Enzymes for Thrombolytic Therapy.
Kumar SS; Sabu A
Adv Exp Med Biol; 2019; 1148():345-381. PubMed ID: 31482506
[TBL] [Abstract][Full Text] [Related]
22. Plant-Derived Compounds and Extracts as Modulators of Plasmin Activity-A Review.
Kolodziejczyk-Czepas J; Czepas J
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838662
[TBL] [Abstract][Full Text] [Related]
23. A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol.
Winkler UH; Schindler AE; Endrikat J; Düsterberg B
Contraception; 1996 Feb; 53(2):75-84. PubMed ID: 8838483
[TBL] [Abstract][Full Text] [Related]
24. The fibrinolytic system: A new target for treatment of depression with psychedelics.
Idell RD; Florova G; Komissarov AA; Shetty S; Girard RB; Idell S
Med Hypotheses; 2017 Mar; 100():46-53. PubMed ID: 28236848
[TBL] [Abstract][Full Text] [Related]
25. Fibrin-associated plasminogen activation in alpha 2-plasmin inhibitor deficiency.
Aoki N; Sakata Y; Ichinose A
Blood; 1983 Nov; 62(5):1118-22. PubMed ID: 6626743
[TBL] [Abstract][Full Text] [Related]
26. Fibrinolysis and thrombosis of fibrinogen-modified gold nanoparticles for detection of fibrinolytic-related proteins.
Jian JW; Chiu WC; Chang HT; Hsu PH; Huang CC
Anal Chim Acta; 2013 Apr; 774():67-72. PubMed ID: 23567118
[TBL] [Abstract][Full Text] [Related]
27. Effect of fibrin structure on plasmin-mediated dissolution of plasma clots.
Carr ME; Alving BM
Blood Coagul Fibrinolysis; 1995 Sep; 6(6):567-73. PubMed ID: 7578900
[TBL] [Abstract][Full Text] [Related]
28. Pharmacology of fibrinolysis.
Haire WD
Chest; 1992 Apr; 101(4 Suppl):91S-97S. PubMed ID: 1555484
[TBL] [Abstract][Full Text] [Related]
29. Plasminogen: an enigmatic zymogen.
Keragala CB; Medcalf RL
Blood; 2021 May; 137(21):2881-2889. PubMed ID: 33735914
[TBL] [Abstract][Full Text] [Related]
30. The fibrinolytic system-more than fibrinolysis?
Draxler DF; Medcalf RL
Transfus Med Rev; 2015 Apr; 29(2):102-9. PubMed ID: 25576010
[TBL] [Abstract][Full Text] [Related]
31. Fibrinolysis--a review.
Kane KK
Ann Clin Lab Sci; 1984; 14(6):443-9. PubMed ID: 6239587
[TBL] [Abstract][Full Text] [Related]
32. DNA, histones and neutrophil extracellular traps exert anti-fibrinolytic effects in a plasma environment.
Varjú I; Longstaff C; Szabó L; Farkas ÁZ; Varga-Szabó VJ; Tanka-Salamon A; Machovich R; Kolev K
Thromb Haemost; 2015 Jun; 113(6):1289-98. PubMed ID: 25789443
[TBL] [Abstract][Full Text] [Related]
33. Fibrinolysis at the fluid-solid interface of thrombi.
Kolev K; Longstaff C; Machovich R
Curr Med Chem Cardiovasc Hematol Agents; 2005 Oct; 3(4):341-55. PubMed ID: 16250865
[TBL] [Abstract][Full Text] [Related]
34. [Plasminogen activation by tissue plasminogen activator on fibrin clots with different surface structures].
Savchuk AN
Ukr Biokhim Zh (1999); 2001; 73(3):87-90. PubMed ID: 12035559
[TBL] [Abstract][Full Text] [Related]
35. DNA-bound elastase of neutrophil extracellular traps degrades plasminogen, reduces plasmin formation, and decreases fibrinolysis: proof of concept in septic shock plasma.
Cruz DBD; Helms J; Aquino LR; Stiel L; Cougourdan L; Broussard C; Chafey P; Riès-Kautt M; Meziani F; Toti F; Gaussem P; Anglés-Cano E
FASEB J; 2019 Dec; 33(12):14270-14280. PubMed ID: 31682515
[TBL] [Abstract][Full Text] [Related]
36. Microscale structural changes of individual fibrin fibers during fibrinolysis.
Lynch SR; Laverty SM; Bannish BE; Hudson NE
Acta Biomater; 2022 Mar; 141():114-122. PubMed ID: 35007782
[TBL] [Abstract][Full Text] [Related]
37. Fibrin-specific thrombolytic agents.
Collen D
Klin Wochenschr; 1988; 66 Suppl 12():15-23. PubMed ID: 3126344
[TBL] [Abstract][Full Text] [Related]
38. [The fibrinolytic system and its activators].
Seifried E
Z Gesamte Inn Med; 1993; 48(6-7):272-82. PubMed ID: 8333223
[TBL] [Abstract][Full Text] [Related]
39. Effect of fibrin degradation products on fibrinolytic process.
Yatsenko TA; Rybachuk VM; Yusova OI; Kharchenko SM; Grinenko TV
Ukr Biochem J; 2016; 88(2):16-24. PubMed ID: 29227597
[TBL] [Abstract][Full Text] [Related]
40. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
